The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
Lilli Petruzzelli, William R. Sellers, Franco Lombardo, Pascal Furet, Joseph Schoepfer, Andrew A. Wylie, Wolfgang Jahnke, Sandra W. Cowan‐Jacob, Alice Loo, Andreas L. Marzinzik, Xavier Pellé, Jerry Donovan, Wenjing Zhu, Silvia Buonamici, Amr Hassan, Varsha Iyer, Michael R. Palmer, Giuliano Berellini, Stephanie Dodd, Sanjeev Thohan, Hans Bitter, Susan Branford, David M. Ross, Timothy P. Hughes, K. Gary J. Vanasse, Markus Warmuth, Francesco Hofmann, Nicholas Keen